🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
gpASIT+TM product is based on highly purified allergen fragments obtained f...
Status
Completed
Location
University Hospital Ghent
Start Date
2015-12
Trial ID
NCT02560948
Treatments Being Tested
This is a randomised, double-blind, placebo-controlled, international, mult...
Status
Unknown
Location
Multiple Locations
Start Date
2019-01-02
Trial ID
NCT03724240
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of gpASI...
Status
Completed
Location
UZ Leuven, Gasthuisberg
Start Date
2010-03
Trial ID
NCT01111279
Treatments Being Tested
The aim of the study is to compare the safety, clinical tolerability, immun...
Status
Completed
Location
Universitaire Ziekenhuis van Leuven
Start Date
2011-11
Trial ID
NCT01506375
Treatments Being Tested
The purpose of this study is to determine whether the oral administration o...
Status
Completed
Location
Hospital University Ghent
Start Date
2008-12
Trial ID
NCT00813046
Treatments Being Tested
The purpose of this study is to determine whether the oral administration o...
Status
Completed
Location
University Hospital Brugmann
Start Date
2009-02
Trial ID
NCT00833066
gpASIT+TM product is based on highly purified allergen fragments obtained f...
Status
Completed
Location
Universitätsklinikum Carl-Gustav-Carus, Dresden, Germany
Start Date
2013-08
Trial ID
NCT02156791
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of grass po...
Status
Completed
Location
CHR Saint Joseph Warquignies
Start Date
2010-12
Trial ID
NCT01308021